Learn More
Apexbio Technology LLC Lenalidomide (CC-5013) 191732-72-6 50mg

Supplier: Apexbio Technology LLC A421150
Lenalidomide (CC-5013) a structural analog of thalidomide is a synthetic small-molecule agent exhibiting anti-tumor properties primarily through immune modulation and antiangiogenic activities Mechanistically lenalidomide promotes the activation of immune functions enhances expression of costimulatory molecules on leukemia lymphocytes and restores immunoglobulin synthesis thereby augmenting humoral immune responses Additionally it improves T cell interactions leading to restored immunological synapse formation and function Current research applications involve investigating lenalidomide s therapeutic potential in multiple myeloma myelodysplastic syndrome (MDS) chronic lymphocytic leukemia (CLL) and other lymphoproliferative disorders including non-Hodgkin lymphoma (NHL)
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.